• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌细胞中肿瘤治疗电场(TTFields)频率和治疗持续时间的优化

Optimization of Tumor Treating Fields (TTFields) Frequency and Treatment Duration in Colorectal Cancer Cells.

作者信息

Liu Menglan, Su Zhaoran, Hagemann Paul-Philipp, Fischer Malte, Linnebacher Michael

机构信息

Molecular Oncology and Immunotherapy, Clinic of General Surgery, University Medical Center Rostock, Rostock, Germany.

Department of Gastrointestinal Surgery, People's Hospital of Tongling City, Tongling, China.

出版信息

Cancer Med. 2025 May;14(10):e70976. doi: 10.1002/cam4.70976.

DOI:10.1002/cam4.70976
PMID:40387458
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12086974/
Abstract

INTRODUCTION

Colorectal cancer (CRC) is one of the most prevalent malignancies worldwide. Tumor Treating Fields (TTFields), a novel anticancer therapy using intermediate frequency and low-intensity alternating electric fields, has demonstrated efficacy in various cancers, but its application in CRC remains underexplored.

OBJECTIVE

To determine the optimal frequency and treatment duration of TTFields therapy for CRC through in vitro experiments.

METHODS

Four human CRC cell lines (2 MSI: HROC110 T1 M7, HROC285 T0 M2; 2 MSS: HROC450, HROC463) were treated using the inovitro TTFields system. Frequencies (100, 200, 300 kHz) and daily exposure durations (16, 20, 24 h/day) were varied. Cell viability was assessed after 72 h using crystal violet staining and spectrophotometry. Data were analyzed using t-tests or ANOVA, with p < 0.05 considered statistically significant.

RESULTS

TTFields significantly reduced cell viability at all tested frequencies. The 100 kHz frequency yielded the most pronounced effects, especially in MSI cell lines (p < 0.001). Treatment duration of 24 h/day led to the greatest viability reduction across all cell lines (p < 0.01), while 16 h/day and 20 h/day showed comparatively weaker effects.

CONCLUSION

Our study demonstrates that TTFields effectively reduce CRC cell viability, supporting their therapeutic potential. Further studies are needed to understand their mechanisms and synergy with existing treatments.

摘要

引言

结直肠癌(CRC)是全球最常见的恶性肿瘤之一。肿瘤治疗电场(TTFields)是一种使用中频和低强度交变电场的新型抗癌疗法,已在多种癌症中显示出疗效,但其在结直肠癌中的应用仍未得到充分探索。

目的

通过体外实验确定TTFields疗法治疗结直肠癌的最佳频率和治疗持续时间。

方法

使用体外TTFields系统处理四种人结直肠癌细胞系(2种微卫星高度不稳定:HROC110 T1 M7、HROC285 T0 M2;2种微卫星稳定:HROC450、HROC463)。改变频率(100、200、300kHz)和每日暴露持续时间(16、20、24小时/天)。72小时后使用结晶紫染色和分光光度法评估细胞活力。使用t检验或方差分析对数据进行分析,p<0.05被认为具有统计学意义。

结果

在所有测试频率下,TTFields均显著降低细胞活力。100kHz频率产生的效果最为显著,尤其是在微卫星高度不稳定细胞系中(p<0.001)。每天24小时的治疗持续时间导致所有细胞系的活力降低最大(p<0.01),而每天16小时和20小时的效果相对较弱。

结论

我们的研究表明,TTFields可有效降低结直肠癌细胞活力,支持其治疗潜力。需要进一步研究以了解其机制以及与现有治疗方法的协同作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea44/12086974/d582a52c8b79/CAM4-14-e70976-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea44/12086974/ead73bf75fa4/CAM4-14-e70976-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea44/12086974/d582a52c8b79/CAM4-14-e70976-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea44/12086974/ead73bf75fa4/CAM4-14-e70976-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea44/12086974/d582a52c8b79/CAM4-14-e70976-g002.jpg

相似文献

1
Optimization of Tumor Treating Fields (TTFields) Frequency and Treatment Duration in Colorectal Cancer Cells.结直肠癌细胞中肿瘤治疗电场(TTFields)频率和治疗持续时间的优化
Cancer Med. 2025 May;14(10):e70976. doi: 10.1002/cam4.70976.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Tumor treating fields suppress tumor cell growth and induce immunogenic cell death biomarkers in biliary tract cancer cell lines.肿瘤治疗电场可抑制胆管癌细胞系中的肿瘤细胞生长并诱导免疫原性细胞死亡生物标志物。
Sci Rep. 2025 Aug 20;15(1):30611. doi: 10.1038/s41598-025-16341-6.
4
Exploring potential therapeutic targets for colorectal tumors based on whole genome sequencing of colorectal tumors and paracancerous tissues.基于结直肠癌及癌旁组织全基因组测序探索结直肠癌潜在治疗靶点
Front Mol Biosci. 2025 Jul 4;12:1605117. doi: 10.3389/fmolb.2025.1605117. eCollection 2025.
5
Chemoprevention of colorectal cancer: systematic review and economic evaluation.结直肠癌的化学预防:系统评价和经济评估。
Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320.
6
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
8
Tumor treating fields combined with ionizing radiation inhibit the malignant phenotype of lung cancer brain metastasis cells by suppressing DNA damage repair pathways.肿瘤治疗电场联合电离辐射通过抑制DNA损伤修复途径抑制肺癌脑转移细胞的恶性表型。
Brain Stimul. 2025 Jul 27;18(5):1426-1440. doi: 10.1016/j.brs.2025.07.014.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
10
Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis.肿瘤治疗电场(TTFields)治疗与新诊断胶质母细胞瘤患者生存的关联:系统评价和荟萃分析。
J Neurooncol. 2023 Aug;164(1):1-9. doi: 10.1007/s11060-023-04348-w. Epub 2023 Jul 26.

本文引用的文献

1
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
2
Theory and application of TTFields in newly diagnosed glioblastoma.TTFields 的理论与应用:在新诊断的胶质母细胞瘤中的应用
CNS Neurosci Ther. 2024 Mar;30(3):e14563. doi: 10.1111/cns.14563.
3
Treatment with tumor-treating fields (TTFields) suppresses intercellular tunneling nanotube formation in vitro and upregulates immuno-oncologic biomarkers in vivo in malignant mesothelioma.
肿瘤治疗电场(TTFields)治疗抑制体外细胞间隧穿纳米管的形成,并上调恶性间皮瘤体内免疫肿瘤生物标志物。
Elife. 2023 Nov 13;12:e85383. doi: 10.7554/eLife.85383.
4
A review of tumor treating fields (TTFields): advancements in clinical applications and mechanistic insights.肿瘤治疗电场(TTFields)综述:临床应用的进展和机制见解。
Radiol Oncol. 2023 Sep 4;57(3):279-291. doi: 10.2478/raon-2023-0044. eCollection 2023 Sep 1.
5
Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis.肿瘤治疗电场(TTFields)治疗与新诊断胶质母细胞瘤患者生存的关联:系统评价和荟萃分析。
J Neurooncol. 2023 Aug;164(1):1-9. doi: 10.1007/s11060-023-04348-w. Epub 2023 Jul 26.
6
Real-Time Monitoring of the Effect of Tumour-Treating Fields on Cell Division Using Live-Cell Imaging.利用活细胞成像实时监测肿瘤治疗电场对细胞分裂的影响。
Cells. 2022 Aug 31;11(17):2712. doi: 10.3390/cells11172712.
7
The HROC-Xenobank-A High Quality Assured PDX Biobank of >100 Individual Colorectal Cancer Models.HROC-异种生物样本库-A:一个拥有超过100种个体结直肠癌模型的高质量保证的人源肿瘤异种移植生物样本库。
Cancers (Basel). 2021 Nov 23;13(23):5882. doi: 10.3390/cancers13235882.
8
Tumor Treating Fields (TTFields) downregulate the Fanconi Anemia-BRCA pathway and increase the efficacy of chemotherapy in malignant pleural mesothelioma preclinical models.肿瘤电场治疗(TTFields)下调范可尼贫血-BRCA 通路,并增加恶性胸膜间皮瘤临床前模型中化疗的疗效。
Lung Cancer. 2021 Oct;160:99-110. doi: 10.1016/j.lungcan.2021.08.011. Epub 2021 Aug 27.
9
Tumor-treating fields (TTFields)-based cocktail therapy: a novel blueprint for glioblastoma treatment.基于肿瘤治疗电场(TTFields)的联合疗法:胶质母细胞瘤治疗的新蓝图。
Am J Cancer Res. 2021 Apr 15;11(4):1069-1086. eCollection 2021.
10
Tumor Treating Fields: Adjuvant Treatment for High-grade Gliomas.肿瘤电场疗法:高级别胶质瘤的辅助治疗
Semin Oncol Nurs. 2018 Dec;34(5):454-464. doi: 10.1016/j.soncn.2018.10.007. Epub 2018 Nov 7.